** Shares of PolyNovo PNV.AX rise as much as 2.7% to
A$1.34, their highest since Sept. 27
** Medical devices co says it has received additional
funding of $10 mln from the Biomedical Advanced Research and
Development Authority (BARDA)
** Says, funding for co's pivotal trial program of NovoSorb
BTM for treating full thickness burns
** PNV says, additional funding increases total commitment
from BARDA to $25 mln
** Stock down 35.4% YTD, as of last close
(Reporting by Ayushman Ojha in Bengaluru)
((Ayushman.ojha@thomsonreuters.com;))